| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Mar 19, 2024 | Sale | $6.10 | 4,116 | 25,102 | 20,746 | Mar 19, 2024, 08:36 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Jun 02, 2022 | Option Exercise | $4.48 | 11,160 | 49,997 | 11,762 | Jun 03, 2022, 05:00 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Feb 22, 2021 | Sale | $31.70 | 50,000 | 1,584,904 | 25,602 | Feb 24, 2021, 05:15 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Feb 23, 2021 | Sale | $31.54 | 10,000 | 315,392 | 5,602 | Feb 24, 2021, 05:15 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Nov 04, 2020 | Sale | $22.64 | 66,536 | 1,506,250 | 33,870 | Nov 04, 2020, 05:31 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Nov 02, 2020 | Sale | $20.86 | 70,000 | 1,460,531 | 35,602 | Nov 04, 2020, 05:31 PM | |
| STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | Nov 03, 2020 | Option Exercise | $22.16 | 3,464 | 76,757 | 2,334 | Nov 04, 2020, 05:31 PM | |
| ALDX | Aldeyra Therapeutics, Inc. | Tulipano Stephen J | Chief Financial Officer | Jun 30, 2017 | Option Exercise | $3.95 | 2,077 | 8,209 | 5,410 | Mar 08, 2018, 04:38 PM | |
| ALDX | Aldeyra Therapeutics, Inc. | Tulipano Stephen J | Chief Financial Officer | Dec 29, 2017 | Option Exercise | $3.99 | 3,153 | 12,596 | 8,563 | Mar 08, 2018, 04:38 PM | |
| ALDX | Aldeyra Therapeutics, Inc. | Tulipano Stephen J | Chief Financial Officer | Feb 17, 2017 | Buy | $4.50 | 3,333 | 14,999 | 3,333 | Feb 21, 2017, 04:30 PM |
Menu